temozolomide has been researched along with incb-018424 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biray Avci, C; Goker Bagca, B; Ozates, NP | 1 |
1 other study(ies) available for temozolomide and incb-018424
| Article | Year |
|---|---|
Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes.
Topics: Antineoplastic Agents; Brain Neoplasms; Glioblastoma; Humans; Janus Kinases; STAT Transcription Factors; Temozolomide; Wnt Signaling Pathway | 2022 |